Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Un-Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Limited has informed BSE that its Board of Directors will meet on Friday, 14th November 2025 to consider and approve the Un-Audited Financial Results for the quarter and half year ended 30th September 2025. The intimation is filed under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements, 2015. Any other business matters may also be taken up with the Board's permission. The communication is signed by Director Babita (DIN: 09064124).
This is a routine procedural filing with no financial numbers disclosed yet. Investors should track the outcome of the 14th November board meeting, where the actual Q2/H1 FY26 results will be announced, to gauge the company's earnings performance.